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Abstract. Transepithelial migration of neutrophils 
(PMN) is a defining characteristic of active inflamma- 
tory states of mucosal surfaces. The process of PMN 
transepithelial migration, while dependent on the neu- 
trophi1132 integrin CDllb/CD18, remains poorly under- 
stood. In these studies, we define a monoclonal anti- 
body, C5/D5, raised against epithelial membrane 
preparations, which markedly inhibits PMN migration 
across polarized monolayers of the human intestinal 
epithelial cell line T84 in a bidirectional fashion. In T84 
cells, the antigen defined by C5/D5 is upregulated by 
epithelial exposure to IFN-% and represents a mem- 
brane glycoprotein of ~60 kD that is expressed on the 
basolateral membrane. While transepithelial migration 
of PMN was markedly inhibited by either C5/D5 IgG or 
C5/D5 Fab fragments, the antibody failed to inhibit 
both adhesion of PMN to T84 monolayers and adhe- 
sion of isolated T84 cells to the purified PMN integrin, 
CDllb/CD18. Thus, epithelial-PMN interactions 
blocked by C5/D5 appear to be downstream from ini- 
tial CDllb/CD18-mediated adhesion of PMN to epi- 
thelial cells. Purification, microsequence analysis, and 
cross-blotting experiments indicate that the C5/D5 anti- 
gen represents CD47, a previously cloned integral 
membrane glycoprotein with homology to the immuno- 
globulin supeffamily. Expression of the CD47 epitope 
was confirmed on PMN and was also localized to the 
basolateral membrane of normal human colonic epithe- 
lial cells. While C5/D5 IgG inhibited PMN migration 
even in the absence of epithelia, preincubation of T84 
monolayers with C5/D5 IgG followed by antibody 
washout also resulted in inhibition of transmigration. 
These results suggest the presence of both neutrophil 
and epithelial components to CD47-mediated transepi- 
thelial migration. Thus, CD47 represents a potential 
new therapeutic target for downregulating active in- 
flammatory disease of mucosal surfaces. 
TIVE inflammation of surfaces lined by columnar ep- 
ithelia is histologically defined by transmigration 
of neutrophils (PMN)  1 across such epithelial  mono- 
layers and subsequent collection of PMN in the lumen (26, 
53). Recently, neutrophils have been recognized not only 
to influence epithelial function during transmigration, but 
also to interact with biochemically distinct apical domains 
after translocation to the lumenal compartment, thus fur- 
ther modifying key epithelial processes (33, 51). For exam- 
ple, in intestinal epithelia it appears that PMN transepithe- 
lial  migration  may reversibly influence epithelial  barrier 
function (19,  37, 44), while arrival  in the lumenal  space 
may result in interactions promoting electrogenic C1- se- 
cretion  (32,  33),  the known basis for secretory diarrhea 
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(18).  Thus,  specific events related  to the transmigration 
process  may  culminate  the  barrier  and  transport  alter- 
ations characteristic of the epithelial dysfunction present 
in acutely inflamed mucosal surfaces. 
The process by which PMN migrate across polarized co- 
lumnar epithelial surfaces is only partially understood. It is 
increasingly clear that the paradigm that applies to PMN- 
endothelial interactions does not apply to PMN-epithelial 
interactions (42). For example, PMN interactions with epi- 
thelia and endothelia display contrasting dependencies on 
PMN [32 integrins  (30, 41, 43, 48) and carbohydrates (12). 
Such interactions  are  also differentially regulated by in- 
flammatory cytokines (10, 11). Likewise, ligands crucial to 
transendothelial movement of PMN such as the immuno- 
globulin superfamily members ICAM-1 and ICAM-2, are 
either not expressed in columnar epithelia (ICAM-2 [14]) 
or are not involved in  transepithelial  migration  of PMN 
(ICAM-I[10, 41]; Parkos, C. A., S. Colgan, M. Diamond, 
A. Nusrat, T. Liang,  T. Springer,  and J. Madara,  manu- 
script  in  preparation).  Such  contrasting  paradigms  for 
PMN association with and transmigration across endothe- 
@ The Rockefeller University Press, 0021-95251961021437114  $2.00 
The Journal of Cell Biology, Volume 132, Number 3, February  1996 437-450  437 lia versus columnar epithelia are perhaps to be expected 
given the markedly different microenvironments and ge- 
ometries of these highly divergent systems. For example, 
flow-related shear, an essential consideration for extravasa- 
tion of PMN that is overcome, in part, by selectin-medi- 
ated PMN endothelial interactions (5, 49, 50), has no coun- 
terpart  in  epithelia.  Moreover,  the  paracellular  space 
through which PMN must negotiate to move across these 
biological barriers is less than 1 ixm in length for endothe- 
lia but ,-~25-30 ixm (i.e., ~3 PMN diameters) for columnar 
epithelia.  Hence  the  lateral  membrane  interactions  be- 
tween PMN and epithelia that occur during transepithelial 
migration may be complex. Additionally, whereas initial 
contact between extravasating PMN and endothelial cells 
is made at the apical membrane domain, first contact oc- 
curs at the basolateral domain of epithelial cells. 
Another unique feature of epithelial-PMN interactions 
is  exemplified during  bacterial  disease.  Under  such  cir- 
cumstances, the apical or lumenal epithelial membrane is 
the site of first contact with offending organisms. Recent 
observations indicate that, in response to such "external" 
challenges, columnar epithelial cells can acutely regulate 
and,  indeed,  seemingly  orchestrate  PMN  migration  re- 
sponses (35, 36). Thus, it is likely that, as a consequence of 
the biological distinctions between PMN migration across 
endothelial versus epithelial surfaces, PMN-epithelial in- 
teractions might present a  unique  (and highly available) 
array of sites for application of targeted therapeutic inter- 
vention. 
While the anatomy of columnar epithelia dictates com- 
plex interactions between transmigrating  PMN  and  epi- 
thelial lateral membranes, the ligands responsible for such 
interactions  are  only beginning  to  be  understood.  The 
PMN integrin CDllb/CD18 is required for transepithelial 
migration  (41). Although  the counter-receptor(s) on the 
epithelial surface for this integrin remain undefined, they 
appear  to  be  enriched  on  the  basolateral  domain  (43). 
Candidate  counter-receptor molecules do not  appear  to 
include  ICAM-1  (41;  Parkos, C.  A.,  S.  Colgan, M.  Dia- 
mond, A.  Nusrat, T.  Liang, T.  Springer, and J.  Madara, 
manuscript in  preparation), but  are regulated in expres- 
sion  by cytokines such  as  IFN--/  (10).  Given the  likely 
complexity of lateral membrane-PMN interactions during 
transit across the lengthy epithelial surface, it would not be 
surprising if additional, CDllb/CD18-independent events 
also occurred during transepithelial migration. 
Due to the limited current understanding of events re- 
quired for PMN migration across columnar epithelial sur- 
faces, we have raised monoclonal antibodies against mem- 
branes derived from a model polarized human intestinal 
epithelium and have examined the effects of such antibod- 
ies on epithelial-PMN interactions. Here we characterize 
one such antibody, C5/D5. In this report, we demonstrate 
that C5/D5 IgG inhibits the process of PMN transepithe- 
lial migration. In contrast, C5/D5 does not inhibit either 
initial adhesion of PMN to epithelial cells or adhesion of 
epithelial cells to purified CDllb/CD18. The antigen rec- 
ognized by C5/D5 is a membrane glycoprotein of ~60 kD 
having a core peptide of ~35 kD and is basolaterally ex- 
pressed on polarized human intestinal epithelial cell lines. 
In natural human intestine it is likewise expressed basolat- 
erally by epithelial cells and also by lamina propria inflam- 
matory cells. Microsequencing and cross-blotting/ELISA 
assays  reveal the  C5/D5  antigen represents a  previously 
cloned immunoglobulin family member with an unusual 
predicted  topology  and  an  uncertain  function  (CD47). 
Since we show that CD47 is expressed on colonic epithe- 
lium and confirm CD47 is also expressed on PMN, experi- 
ments  to probe  the  relative contribution(s) of each  cell 
type in  CD47-mediated  transmigration  were performed. 
While PMN-associated CD47 appears to be crucial in the 
process  of neutrophil  migration,  epithelial  preexposure 
with C5/D5 IgG also resulted in inhibition of transmigra- 
tion.  Such findings  indicate that  CD47  may be  used  by 
both epithelia and PMN during movement of PMN from 
the epithelial basolateral surface to the intestinal lumen. 
Materials and Methods 
Cell Culture 
T84 cells (15, 16) were grown in a 1:1 mixture of Dulbecco's modified Ea- 
gle medium and Ham's F-12 medium supplemented with 15 mM Hepes 
buffer (pH 7.5), 14 mM NaHCO3, 40 ~g/ml penicillin, 8 l~g/ml ampicillin, 
90  p~g/ml streptomycin, and  5%  newborn  calf serum. Subculturing (or 
preparation of suspensions and / or lysates) was performed every 6-8 d by 
treatment with 0.1% trypsin and 1.0 mM EDTA in Ca  2+- and MgZ+-free 
phosphate-buffered saline (15).  For apical-to-basolateral transmigration 
experiments, T84 monolayers were grown on permeable collagen-coated, 
polycarbonate supports (inserts) with a  surface area of 0.33 cm  2 (Costar 
Inc., Cambridge, MA) as previously described (41). For physiologically di~ 
rected, basolateral-to-apical transmigration, T84 cells were plated on the 
underside of permeable filters to produce inverted monolayers (31, 41). 
Such inverted monolayers effectively reverse the polarity of neutrophil- 
epithelial interactions studied by allowing gravitational settling of PMN 
onto the basolateral aspect of the monolayer(41). 
For purification of the protein recognized by mAb C5/D5 the clonal de- 
rivative,  Cl.19A,  of the  human intestinal epithelial  cell  line  HT29  (2) 
(kindly provided by Dr. C. Laboisse, Universit6 de Nantes, France) was 
grown to confluency in 165-cm  2 tissue culture flasks. Subculturing (or har- 
vesting) was performed every 5 d by trypsin treatment with 0.1% trypsin 
in Ca  2+- and Mg2+-free phosphate buffered saline. Typically, cells were 
split 1:10 in DME supplemented with 10% FBS, 1 mM L-glutamine, 100 
U/ml penicillin, 0.1 mg/ml streptomycin (all from GIBCO BRL, Gaithers- 
burg, MD) and became confluent within 5-6 d. 
Primary cultures of human umbilical vein endothelial cells (HUVEC) 
were  established from normal term umbilical cords as described previ- 
ously (21). For experimental use, second passage cells were plated on gel- 
atin-coated  0.33-cm  2  polycarbonate  filters  (Costar  Corp.,  Cambridge, 
MA) and maintained in Medium 199 (with 25 mM Hepes; GIBCO BRL) 
supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 
U/ml streptomycin, 25 txg/ml endothelial cell growth supplement (Collab- 
orative Research Inc., Bedford, MA), 50 Ixg/ml heparin (Sigma, St. Louis, 
MO), and 250 ng/ml amphotericin B  (Fungizone; GIBCO BRL) for 7 d 
before use. 
For surface-labeling experiments by ELISA, T84 or HT29 (CI  19.A) 
cells were plated 48 h before use at 3/4 confluent density in 96-well micro- 
titer plates in cell culture media with or without 1,000 U/ml IFN-~, (kindly 
provided by Genentech Inc., South San Francisco, CA). 
PMN Isolation 
PMN were  isolated from whole blood  (anticoagulated with citrate/dex- 
trose) obtained from normal human volunteers, using a gelatin sedimenta- 
tion technique previously described in detail (24). PMN were resuspended 
in modified HBSS devoid of Ca  2+ and Mg  2+ (HBSS(-))  at a concentra- 
tion of 4 ×  107 cells/ml (4°C) and used for subsequent experiments. 
Buffers 
HBSS  consisted of (in  g/L);  0.185  CaCI  2,  0.098  MgSO4,  0.4  KCI,  0.06 
KH2PO4, 8 NaCI, 0.048 Na2HPO4, 1 glucose, and Hepes added to 10 mM 
(pH 7.4).  HBSS(-) was prepared as HBSS but without CaCI2 or MgSO4. 
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MgCI2, 1 mM CaCI2,10 mM dextrose and 0.5% heat-treated BSA (heated 
to 60°C). IPPT wash buffer consisted of 400 mM NaCI, 100 mM NaF, 1 
mM EDTA, 1% Triton X-f00, and 10 mM NazHPO4, pH 7.4. Lysis buffer 
was prepared as a solution of 100 mM KCI, 30 mM NazCI, 2 mM EDTA, 
10 mM Hepes, pH 7.4,  and 2% Triton X-100. Sample buffer consisted of 
2.5% SDS, 0.375  M  Tris, pH 6.8, 20% glycerol, and 0.1% bromophenol 
blue. 
Miscellaneous Biochemical Assays 
Protein  was assayed using the Bradford  method (6),  and by the BCA 
method as described by Pierce Chem. Co. (Rockford, IL) using bovine 
globulin as a standard. Superoxide production was measured as the super- 
oxide dismutase inhibitable reduction of cytochrome C as previously de- 
scribed (40). Lactoferrin release was quantitated by ELISA as previously 
described (40). 
Membrane Preparation 
T84 epithelial membranes for immunization were prepared as described 
previously (25). Briefly, T84 cells, plated as monolayers on 45-cm  2 perme- 
able  supports (rings)  (Costar  Inc.)  or  on  150-cm  2 tissue culture  flasks, 
were cooled to 4°C, washed with HBSS, and cells were scraped from the 
support with a teflon spatula in a small volume of homogenization buffer 
consisting of 0.34 M  sucrose, 10 mM Hepes, pH 7.3,  1 mM ATP, 1 mM 
Dithiothreitol, and 0.1 mM EDTA. Scraped cells were then treated with 
2.5 mM diisopropylfluorophosphate (DFP) (15 min, 4°C) followed by ni- 
trogen cavitation (200 psi, 8 min, 4°C). The cavitate was centrifuged at 
1,000 g to remove nuclear debris and the NaCl content of the supernatant 
adjusted to 1.0 M to remove peripheral membrane proteins. The resulting 
membrane suspension was pelleted by ultracentrifugation at t00,000 g for 
45 rain and was resuspended in homogenization buffer at an equivalent 
cell density of 1-2 X 108per ml and stored at -80°C until further use. 
Antibodies 
To identify ligands important in neutrophil-epithelial interactions, mono- 
clonal antibodies were prepared against T84 cell membranes and screened 
for inhibition of neutrophil-T84 interactions. Female BALBc mice were 
immunized by intraperitoneal injection of T84 epithelial membranes (200 
~l per mouse; representing 1  x  107 cell equivalents emulsified with an 
equal volume of complete Freund's adjuvant). Two subsequent intraperi- 
toneal immunizations were performed over the next 6 wk with the same 
material emulsified with incomplete adjuvant. Mice with high anti-epithe- 
lial antibody titers were given a  final intravenous immunization by tail 
vein (50 Ixl T84 membranes in HBSS) and the spleen harvested for fusion 
4  d  later.  Splenocytes were fused with P3U1  myeloma cells using 1,500 
MW polyethylene glycol (Boehringer Mannheim, Germany) and resus- 
pended in standard selection media (RPM1 supplemented with 1 mM 
L-glutamine, 1/100 dilution of nonessential amino acids, 100 U/ml penicil- 
lin, 0.1 mg/ml streptomycin (all from GIBCO BRL), 1 mM sodium pyru- 
vate, 10% heat inactivated FBS, and HAT (1/1,000  dilution of a stock of 
hypoxanthine, aminopterin and thymidine; American Type Culture Col- 
lection [ATCC], Rockville, MD). The resultant hybridomas were plated at 
limiting dilution and cultured in 96-well tissue culture plates in the pres- 
ence of thymocytes prepared from DBA2 mice at a density of 1.2 X  105 
splenocytes and 5 ×  105 thymocytes per well. After ~7-10 d of growth, the 
supernatants from wells containing ~l-mm-sized colonies were harvested 
and assayed for surface reactivity with both PMN and T84 monolayers by 
EL1SA as described below. Wells demonstrating predominantly epithelial 
reactivity were transferred to 24-well tissue culture plates for expansion 
and production of cell culture supernatant. The tissue culture superna- 
tants were then removed and frozen in aliquots for subsequent screening 
in transmigration and adhesion assays described below. Hybridomas from 
the 24-well culture plates were frozen and stored until screening by func- 
tional assay was complete. After identification of functionally inhibitory 
hybridoma  supernatants,  the  corresponding  hybridomas were  thawed, 
subcloned by limiting dilution ×3 and weaned from selection media. Anti- 
bodies were isotyped using a Dipstick Isotype Kit according to the manu- 
facturer's instructions (GIBCO BRL) and hybridoma cells were injected 
into the peritoneal cavities of pristane-primed mice (2-5 ×  106 cells per 
mouse) for the production of ascites fluids. 
Antibodies were purified from ascitic fluid by standard procedures us- 
ing  proteinA-Sepharose  (Sigma,  St.  Louis,  MO)  followed  by  dialysis 
against 150 mM NaCI containing 10 mM Hepes, pH 7.4.  1.5-3-mg/ml ali- 
quots of concentrated, purified antibody were frozen for use in functional 
assays. F(ab')2 and Fab' preparations were obtained by pepsin digestion 
(100 U/mg, 6 h, 37°C) followed by cysteine reduction (10 mM, 2 h, 37°C) 
and alkylation as described in detail elsewhere (39).  Purity of antibody di- 
gests was confirmed by SDS-PAGE under reducing and nonreducing con- 
ditions. 
Other commercially available antibodies were used as controls. As a 
positive control for inhibition of neutrophil transmigration, antibody 44a 
(anti-CDllb;  ATCC)  was  used  as  described  previously (41).  Another 
anti-CDllb mAb that is noninhibitory but used for immunofluorescence 
was OKM 1 (52; ATCC). Antibody W6/32 (antibody to major histocom- 
patibility antigen class 1) served as a binding, noninhibitory control (4). 
Anti-CD47 (mAb BRIC 126 [3, 34] ) was obtained from Biosource Intl. 
(Camarillo, CA). 
Antibody Labeling/Immunoprecipitation 
ELISA for Detecting Cell Surface Binding Antibodies.  Confluent T84 mono- 
layers in 96-well plates (~2 x  105 cells per well) were treated with 2 mM 
EDTA (4 rain, 37°C) to expose basolateral epitopes (43), cooled to 4°C 
and incubated for 2 h with 25 p~l of hybridoma supernatant or antibody so- 
lution. For neutrophil surface binding, 2 x  105 PMN in HBSS were placed 
in each well and allowed to attach and spread for 30 min (37°C) followed 
by cooling to 4°C and blocking nonspecific binding with cell culture media 
containing 10%  FBS.  Antibody solutions were  then added  as outlined 
above. After subsequent gentle washing with HBSS, cells were incubated 
with 25 pd of enzyme-conjugated secondary antibody diluted  1:1,000  in 
HBSS/10% goat serum (1 h, 4°C). Secondary enzyme conjugates included 
peroxidase for T84 cells and alkaline phosphatase for PMN. Color was de- 
veloped using standard substrate assays and was read in a microtiter plate 
reader. In some experiments, FITC-conjugated goat anti-mouse second- 
ary antibody was used. ELISA  assays performed with such fluorescent 
secondary antibody were quantitated using a fluorescence microtiter plate 
reader (Millipore Inc., Milford, MA). 
Immunofluorescence.  For  immunofluorescence, T84 monolayers were 
fixed in 3.7% paraformaldehyde in HBSS (10 min, 20°C ), washed and in- 
cubated in HBSS containing 5% normal goat serum (NGS) for 30 rain fol- 
lowed by primary antibody for 2 h (10 Ixg/ml in 5% NGS). After washing, 
monolayers were incubated with FITC-conjugated 2  ° antibody (1 h, 20°C; 
Cappel  Inc.,  Durham, NC)  and mounted in  PBS-glycerol-p-phenylene- 
diamine.  Labeled  monolayers were  then  viewed  with  a  Zeiss/BioRad 
MRC-600 confocal fluorescence microscope. As a control for background 
labeling, control monolayers were incubated with comparable concentra- 
tions of normal mouse lgG and secondary antibody.  Labeling was also 
performed on 3 ~m, frozen tissue sections of human colonic mucosa ob- 
tained from fresh surgical specimens. Tissue sections, mounted on glass 
coverslips, were air-dried followed by fixation in 3.7% paraformaldehyde, 
and fluorescently labeled as above. 
Flow Cytometry. PMN were analyzed for surface expression of C5/D5 
antigen by flow cytometry as previously described (12) using a FACScan 
flow cytometer (Becton-Dickinson lmmunocytometry Systems, Mountain 
View, CA). 
Iramunoprecipitation Experiments. To identify protein antigens of func- 
tionally  inhibitory  antibodies,  immunoprecipitation  experiments  were 
performed, after cell surface labeling with biotin, on T84 and HT29 mono- 
layers cultured on either 5-cm  2 permeable supports or on plastic. Briefly, 
monolayers were washed with HBSS and labeled with a solution of 1 mM 
sulfo-NHS biotin (Pierce Chem. Co.) in HBSS for 20 min (4°C) followed 
by quenching the reaction with 150 mM NH4C1. Each 5-cm  2 monolayer 
was solubilized in  1 ml of lysis buffer containing 100 mM KCI, 30 mM 
NaCI, 2 mM EDTA, 10 mM Hepes, pH 7.4, 2% Triton X-100 and protease 
inhibitors including 1.25 mM PMSF, 5 ~g/ml chymostatin, 1 p~g/ml each of 
leupeptin, pepstatin and bestatin  (4°C).  For  cells grown in  flasks, lysis 
buffer was added at a ratio of roughly 1 ml per 75 cmz. The T84 cell lysate 
was subjected to sequential low speed (3,000 g, 10 rain) and high speed 
(180,000 g, 45 min) centrifugation followed by filtration (0.2 Ix filter). The 
filtered lysate was precleared for 2 h with 50 ~1 of IgG-Sepharose (mouse 
IgG coupled to CNBR-activated Sepharose 6 MB at a protein/Sepharose 
density of 3 mg/ml according to the manufacturer's instructions; Pharma- 
cia Inc, Uppsala, Sweden) followed by incubation for 2 h (4°C) with 30 ixl 
C5/D5-Sepharose,  prepared  exactly  as  described  for  the  mouse IgG- 
Sepharose above.  Immunoprecipitates were  washed first in  1PPT wash 
buffer followed by 1% octylglucoside in 100 mM sodium phosphate, pH 
7.4, and finally washed in 1% octylglucoside in 20 mM sodium phosphate, 
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100°C in the presence of 50 p,1 nonreduced sample buffer followed by re- 
moval of the Sepharose pellet. The denatured, solubilized immunoprecip- 
itate was then subjected to reduced and nonreduced SDS-PAGE on linear 
4-16% gradient polyacrylamide gels followed by Western blotting using 
standard protocols. Before SDS-PAGE, reduced samples (Dithiothreitol 
added to 20 mM; 100°C, 3 min) were alkylated by addition of iodoaceta- 
mide to 50 mM (100°C, 3 min) and nonreduced samples were alkylated by 
addition of iodoacetamide to 5 raM. Biotin surface-labeled proteins were 
visualized after incubation with peroxidase-conjugated streptavidin using 
enhanced chemiluminescence, according to  the manufacturer's instruc- 
tions (Amersham Inc., Buckinghamshire, UK). 
For deglycosylation experiments, immunoprecipitates were denatured 
in buffer containing 0.5% SDS followed by addition of a sevenfold excess 
of NP-40. Samples were then subjected to N-linked or O-linked deglycosy- 
lation using commercially available enzymes (peptide:  N-glycosidase F, 
neuraminidase  and  O-glycopeptide  endo-D-galactosyl-N-acetyl-et-galac- 
tosamino hydrolase, respectively) exactly as described by the manufacturer 
(N-glycanase, neuraminidase, O-glycanase; Genzyme, Cambridge, MA). 
Protein Purification and Microsequencing 
Functionally active CDllb/CD18 was purified by immunoaffinity chroma- 
tography using peripheral blood leukocyte lysates exactly as previously 
described (17). 
Immunopurification of the Antigen Defined by C51D5 IgG. Approximately 
8,500 cm  2 of Cl 19.A HT29 cells were stimulated with 1,000  U/ml IFN-~ 
for 48 h to increase the expression of the C5/D5 antigen. Immediately be- 
fore harvesting, five 165-cm  ~ flasks (~10% of the total ) were transiently 
exposed to 2 mM EDTA in HBSS(-) to open tight junctions thereby ex- 
posing ectodomains of basolateral membrane proteins (41). The EDTA- 
treated  cells were  then surface labeled with biotin as described above. 
Both labeled and unlabeled flasks were then washed 3x with HBSS (4°C), 
and cells were isolated and pooled by scraping with a teflon spatula into 
~120 ml of lysis buffer (2-3 ml of lysis buffer per flask of cells) containing 
1.25 mM PMSF, 5 ~g/ml chymostatin, 1 ~g/ml each of leupeptin, pepstatin 
and bestatin (4°C) and 2 mM EDTA. Diisopropylfluorophosphate (Sigma) 
was then added to the lysate to achieve a final concentration of 2.5 mM 
and stirred for 15 min on ice. The extract was sequentially subjected to 
low speed (2,000 g, 10 min) then high speed (180,000 g, 45 rain, 4°C) cen- 
trifugation followed by passage through a 0.2 p~ filter. The extract was then 
pumped at a flow rate of 25 ml/h first through a column of bovine ~/globu- 
lin-Sepharose (5 ml, 3 mg ~ globulin per ml of beads; coupled as described 
in the above immunoprecipitation section; BGG-Sepharose; Sigma) fol- 
lowed in tandem by a column of C5/D5-Sepharose (3 ml, 3 mg IgG per ml 
of beads;  coupled  as  described  above).  The  C5/D5  column was  then 
washed at a flow rate of 25 ml/h with IPPT wash buffer (50 ml) followed 
by 1% octyl glucoside in 100 mM sodium phosphate, pH 7.4 (30 ml), and 
finally in 1% octylglucoside in 20 mM sodium phosphate, pH 7.4 (30 ml). 
Bound proteins were eluted at a flow rate of 25 ml/h with a 30-ml pH gra- 
dient decreasing from pH 5.0 (150 mM NaC1 and 50 mM NaOAC, 1% 
n-octylglucoside) to pH 3.0 (150 mM NaC1 and 100 mM glycine/HCl, 1% 
n-octylglucoside) followed by an additional 10 ml of pH 3.0 elution buffer. 
Fractions of 2 ml were collected and neutralized by the addition of 0.1 ml 
of 2.0 M  Tris, pH 8.0,  and were analyzed by SDS-PAGE and Western 
blotting as described above. 
For protein microsequence, the peak fraction of immunopurifled pro- 
tein was concentrated ~200-fold (Centricon 30 microconcentrator; Ami- 
con Inc,, Beverly, MA) and subsequently denatured, reduced and alky- 
lated  by  the  sequential  addition  of  sample  buffer  containing 20  mM 
dithiothreitol followed by iodoacetamide to 50 mM. The sample was sub- 
jected to SDS-PAGE as a single lane on a 4-16% gradient polyacrylamide 
gel followed by electrophoretic transfer to polyvinylidene difluoride mem- 
brane (Immobilon-P; Millipore Inc.). The transferred protein was visual- 
ized by stain with amido black followed by excision of the band (N50 
mm  2) and submission to the Harvard Microchemistry Service (Cambridge, 
MA) for  tryptic  digest and internal microsequencing as previously de- 
scribed (1, 27). 
Transmigration Experiments 
PMN  transmigration experiments were performed using both standard 
(apical-to-basolateral migration) and inverted (basolateral-to-apical mi- 
gration) T84 monolayers cultured on 0.33-cm  2 permeable supports as pre- 
viously described (41).  Briefly, confluent T84 monolayers were washed 
free of media followed by apical or basolateral addition of 50 p~l of anti- 
body solution in HBSS and incubation for 20 min (20°C). For some apical- 
to-basolateral transmigration experiments T84 monolayers were  preex- 
posed to 2 mM EDTA in HBSS(-) for 12 min before washing with HBSS. 
Such transient calcium chelation has been shown to expose basolateral 
ligands to the apical compartment of the transwell device without grossly 
altering the morphology of the epithelium (43). After a 20-rain preincuba- 
tion, HBSS was added (100 p.1) followed by 1 x  106 PMN in 25 jxl HBSS(-). 
Transmigration was  initiated  by  transfer  of  antibody/PMN  containing 
monolayers to 24-well tissue culture plates containing 1 ml of 1 I~M fMLP 
in  HBSS.  After  incubation for  110  rain  at  37°C,  neutrophil  migration 
across monolayers into the chemoattractant-containing lower chambers 
was quantitated by myeloperoxidase assay (41). In experiments examining 
the effect of cytokine preactivation on PMN transmigration, the cell cul- 
ture media on confluent T84 monolayers was replaced with media con- 
taining maximally stimulating concentrations of IFN-3, (1,000 U/ml) or IL-4 
(10 U/ml) followed by culture for 48 h  as previously described (10, 11). 
Cytokine-activated monolayers were then washed in HBSS and used in 
transmigration assays. 
PMN transendothelial migration using monolayers of HUVEC was as- 
sessed in a fashion exactly as described above for T84 monotayers except 
for the use of a 10 nM transendothelial gradient of fMLP. 
In subsets of experiments, monolayers or PMN were pretreated with 
antibody followed by antibody washout and use in subsequent transmigra- 
tion  assays. In such experiments, monolayers (20°C) or PMN  (2  x  10  6 
cells/ml in HBSS(-), 4°C) were preincubated with antibody in HBSS for 
30 min followed by extensive washing and subsequent transfer to transmi- 
gration assays as described above. For monolayer preincubation experi- 
ments, unbound antibody  was washed out  by  five successive rinses in 
HBSS with a five minute incubation in 1 ml of HBSS after each rinse. In 
such experiments, each rinse was effective in reducing the unbound anti- 
body concentration by greater than one order of magnitude thereby re- 
ducing the final concentration of unbound antibody to negligible values. 
Other  transmigration experiments were  performed  on  collagen coated 
permeable supports without any epithelial cells. In such assays, collagen 
coated inserts were incubated overnight in sterile tissue culture media fol- 
lowed by washing and placement into 24-well tissue culture plates contain- 
ing 1 ml of antibody in HBSS. After addition of 0.15 ml of antibody solu- 
tion and 1  ×  106 PMN to the upper chamber, fMLP was added to the 
lower chamber to a final concentration of 10 nM. PMN transmigration was 
then assessed exactly as above. 
Adhesion Experiments 
The effects of C5/D5 IgG on neutrophil adhesion to T84 monolayers was 
studied using previously described methods (41).  Briefly, confluent "1784 
monolayers on permeable supports were transiently preexposed to 2 mM 
EDTA in HBSS(-) for 12 min followed by washing in HBSS. To the api- 
cal surface of each monolayer, 50 p.l of antibody solution in HBSS con- 
taining 100 nM fMLP was added followed by transfer of the monolayers to 
24-well tissue culture plates containing 1 ml of HBSS per chamber. 2 x  106 
PMN were added in 50 p~l followed by centrifugation at 250 g for 4 rain 
(20°C). Transwells were then allowed to incubate at 37°C for 10 rain fol- 
lowed by washing and quantitation of adherent PMN by myeloperoxidase 
assay. 
The effects of C5/D5 IgG on T84 cell binding to CDllb/CD18 were as- 
sayed using slightly modified, previously described methods (17). Microti- 
ter plates were coated with functionally active CDllb/CD18 that was pu- 
rified  as  described  above.  For  optimal  coating  with  CDllb/CD18,  a 
solution of purified integrin at I>0.1 mg/ml was diluted 15-fold with 150 
mM NaC1, 2 mM MgCle, 25 mM Tris, pH 7.3, and allowed to bind to mi- 
crotiter wells for 2 h (20~C). As described previously (17), nonspecific bind- 
ing was blocked by incubation with a solution of blocking buffer contain- 
ing  0.5%  heat-treated  bovine  serum  albumin.  For  cell-binding  assays, 
trypsin/EDTA elicited T84 cells were fluorescently labeled for 10 min at 
37°C by incubation with 5 Ixg/ml BCECF-AM (2',7'-bis(2-carboxyethyl)-5- 
(and-6)-carboxyfluorescein acetoxymethyl ester; Molecular Probes,  Inc., 
Eugene, OR). 
Adhesion assays were then performed by the addition of 50 ~1 of anti- 
body solution in blocking buffer to the CDllb/CD18-coated  microtiter 
plates followed by a 20-min incubation (20°C). Labeled epithelial cells (50 
I~1, ~2.5  ×  105 cells per well) were added followed by gentle, constant 
swirling for 15 min to allow antibody binding but prevent adhesion (20°C). 
The assay was then moved to a flat, stationary surface at 37°C for 1 h to al- 
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twice  and total fluorescence of each well was assayed at  an excitation/ 
emission wavelength of 485/535 nm using a fluorescence microtiter plate 
reader (Millipore Inc.). In such assays, the percentage of applied cells ad- 
herent to purified CD1 lb/CD18 typically ranged from 25 to 55%. Percent 
adherence was calculated as  the fluorescence ratio  (post-wash fluores- 
cence/prewash fluorescence) ×  100. 
Statistical Analysis 
Data are presented as the mean --_ SD and compared by Student's t-test or 
by one-way analysis of variance (ANOVA). 
Results 
Three fusions  of splenocytes from mice immunized with 
T84 membranes yielded ~4,300 antibody producing clones 
that were screened for reactivity with both neutrophils and 
T84  epithelial  cells.  Using  the  differential  screening  ap- 
proach outlined  above, ~350  clones were identified  that 
reacted  primarily with  the  external  surface  of epithelial 
cells. Of several antibodies that were subcloned, one anti- 
body, C5/D5  (IgG1), which was among those that inhib- 
ited neutrophil-epithelial interactions, was further charac- 
terized. 
C5/D5 IgG Inhibits PMN Transepithelial Migration But 
Not Adhesion To Purified CDllblCD18 
The effects of C5/D5 IgG on neutrophil migration across 
T84 monolayers in the apical-to-basolateral or basolateral- 
to-apical direction are depicted in Fig.  1. As shown in A, 
PMN transepithelial migration in the apical-to-basolateral 
direction is markedly inhibited by C5/D5  IgG at concen- 
trations as low as 3 t~g/ml (4.5  +- 3.9  ×  104 vs 20.5  __ 0.45 
for C5/D5 vs binding control [W6/32];  P  <  0.005). The ef- 
fects of C5/D5  IgG on PMN migration in basolateral-to- 
apical  directed  transmigration  (physiologically  directed 
transmigration)  are  shown  in  B  (Fig.  1).  Again,  PMN 
transmigration was markedly inhibited  by C5/D5  IgG in 
the range of 3 to 12 ixg/ml (11  _+ 4.1 vs 36.5 _+ 8.5  ×  10  4 for 
12.5 ~g/ml C5/D5 vs ctl [W6/32]; P <  0.02). 
Since the C5/D5 epitope appeared crucial to PMN trans- 
epithelial  migration  and  we  have previously shown  that 
transepithelial  migration is modulated  by cytokines such 
as IL-4 and IFN-~/ (10,  11),  we next determined whether 
the C5/D5 epitope was also functionally involved in trans- 
migration after epithelial exposure to cytokines. As shown 
in panel C  (Fig.  1), PMN transmigration across IL-4 pre- 
stimulated  (10  U/ml,  48  h)  T84  monolayers  was  also 
strongly inhibited by C5/D5 IgG at concentrations as low 
as 2 ixg/ml. As shown in D  and E  (Fig. 1), pretreatment of 
T84 monolayers with IFN-~ (1,000 U/ml, 48 h), which has 
been shown to influence rates of PMN transmigration and 
regulate  surface  expression  of  as  yet  undefined  PMN 
ligands  (10),  retained  sensitivity  to  inhibition  of  PMN 
transmigration  by  C5/D5  IgG  (D)  and  resulted  in  en- 
hanced surface expression of the C5/D5 epitope (E; 250 - 
35 vs 760  --- 90 fluorescence units before and after IFN-v 
stimulation, respectively; P  <  0.02). The data in Fig. 1 D 
show mAb C5/D5  inhibits  PMN migration  across  IFN-'~ 
pretreated T84 monolayers irrespective of the polarity of 
transmigration (13.7  _  6.3  vs 35.6  +_ 4.7  ×  104 basolater- 
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Figure  I. Functional effects  of C5/D5 IgG on PMN  transepithe- 
lial  migration.  As described in Materials and Methods, A  and B 
represent the inhibitory  effects of graded concentrations  of C5/ 
D5 IgG for PMN transmigration in the apical-to-basolateral  (Ap - 
Bl) and basolateral-to-apical  (BI - Ap) directions,  respectively. 
As a binding negative control antibody (CTL), mAb W6/32 was 
used at 50 ixg/ml. Migration  in the absence of antibody addition 
(NoAb) is shown in A, as is a positive control (transmigration in 
the presence of 5  txg/ml of inhibitory  anti-CDllb/CD18 mAb 
44a; reference 43). While  not shown  in B,  mAb 44a  inhibited 
transmigration by 56  _+ 3%. Bars represent the mean ±  SD of 
four monolayers for each condition (56 monolayers total). One of 
three experiments.  (C and D) T84 monolayers were exposed to 
1,000 U/ml IFN-~/ or 10 U/ml IL-4, respectively,  for 48 h. After 
cytokine washout,  PMN transmigration assays were performed. 
For IL-4 experiments, transmigration was in the Ap-B1 direction. 
For IFN-~/experiments, the effects of C5/D5 IgG on transmigra- 
tion are shown in both directions. In agreement with previous ob- 
servations (10), IFN-~ pretreatment resulted in diminished physi- 
ologically directed transmigration from 63.5 +_ 4.4 to 35.6 +_ 4.7 × 
104 migrated PMN for untreated vs IFN-~-treated T84 monolay- 
ers, respectively. Bars represent the mean ± SD of 3 monolayers 
for each  condition  (30 monolayers total).  One  of two experi- 
ments. (E)  Surface  expression  of mAb C5/D5  epitope was as- 
sayed on control ((-)IFN-y) and IFN-~ exposed ((+) IFN-y) 
T84 cells by ELISA as described  in Materials  and Methods.  On 
the Y axis, surface  label represents arbitrary fluorescence  units 
after incubation  with  FITC conjugated  goat  anti-mouse  IgG. 
Bars represent the mean -  SD of three monolayers for each con- 
dition. One of three experiments. 
ally-to-apically migrated PMN for C5/D5 IgG vs control, 
respectively; P  <  0.02). Of interest, such inhibition was ob- 
served despite IFN-~-induced downregulation  of physio- 
logically directed transmigration (10) from 63.5  +  4  ×  104 
migrated PMN  in controls  to 35.6  -+ 4.7  ×  104 migrated 
PMN after IFN-'y pretreatment. As revealed in cross-com- 
parisons of the C5/D5 IgG concentration dependence be- 
tween A, C, and D  (Fig. 1), inhibition of apical-to-basolat- 
eral directed transmigration by this antibody was comparable 
between control and cytokine stimulated monolayers. 
Next,  assays of PMN  adhesion  to  epithelia  were  per- 
formed to assess whether C5/D5 inhibited an initial adhe- 
sive event as opposed to a distal transmigration event. For 
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with fMLP. Adhesion assays 
were then performed as pre- 
viously described (41) and in 
Materials and Methods. As a 
binding,  noninhibitory  con- 
trol,  antibody W6/32  (CTL) 
was used at the same concen- 
tration.  Anti-CDllb  nAb 
44a  served  as  an  inhibitory 
control  as  described  previ- 
ously (43).  Adhesion in  the 
absence  of antibody  is  also 
shown (NoAb). (B) Effect of mAb C5/D5 IgG on T84 cell adhe- 
sion to purified  CDllb/CD18.  T84 cells,  fluorescently labeled 
with BCECF, in the presence or absence of C5/D5 IgG (20 Ixg/ 
ml) or control antibodies, were assayed for adhesion to function- 
ally active CDllb/CD18 in 96-well microtiter plates as described 
in Materials  and  Methods.  Control antibodies  included W6132 
(20 Ixg/ml; negative inhibition), and anti-CD 11 b mAb 44a (10 p,g/ 
ml; positive inhibition). Bars represent the mean +_ SD of four 
monolayers per condition in panel A  and three determinations 
per condition in B. One of three experiments. 
these  studies  (Fig.  2 A),  a  previously detailed  assay that 
permits  exposure  of PMN to both apical and basolateral 
epithelial ligands (41) was used. Saturating concentrations 
of C5/D5  IgG  did  not  inhibit  adhesion  of PMN  to  T84 
monolayers thus resulting in PMN adherence values com- 
parable  to  those  obtained  in  the  presence  of a  control 
binding  antibody  (W6/32)  or in  the  absence  of antibody 
(10.9  --+ 2.8  vs  9.6  _+  2.8  and  10.3  _+  0.9  x  104  adherent 
PMN for C5/D5 vs W6/32 CTL and no antibody, respec- 
tively; NS). Antibody 44a, previously shown to effectively 
interfere with initial PMN-epitheliai  adhesion by blocking 
PMN CDllb/CD18,  served as a positive control for these 
experiments  and  inhibited  PMN-epithelial  adhesion  by 
greater than 70%. 
Given the exquisite dependence of PMN transepithelial 
migration on CDllb/CD18,  we next determined whether 
C5/D5 IgG inhibited some form of epithelial adhesive en- 
gagement of this PMN integrin. Fig. 2 B  shows the effects 
of C5/D5 IgG on T84 cell adhesion to purified, function- 
ally active CDllb/CD18. In such assays, T84 cells strongly 
adhere to purified CDllb/CD18  in a  specific manner.  As 
shown in Fig. 2 B, 56  _  6.9%  of the applied T84 cells ad- 
hered  to CDllb/CD18  in the presence  of a  binding, con- 
trol antibody, and such adherence was markedly inhibited 
(to 2.4 ___ 0.4%) after treatment with blocking anti-CD1 lb 
antibody, 44a.  In contrast  to antibody 44a, preincubation 
of epithelial cells with saturating concentrations of C5/D5 
did not influence the efficiency of epithelial  cell adhesion 
to immobilized CD11 b/CD18 (57 ___ 4% of T84 cells adher- 
ent, NS). The lack of inhibition of C5/D5 IgG on T84 ad- 
hesion was not due to proteolysis of relevant epitopes  by 
the  trypsin  elicitation  procedure  since  the  antibody  was 
able to effectively surface label trypsinized T84 cells (0.579 
___ 0.02 vs 0.191 ___ 0.014 OD units for T84 cells labeled with 
C5/D5 IgG versus control mouse IgG1). As an additional 
test of the specificity of epithelial cell adhesion to purified 
CDllb/CD18,  parallel  assays were performed in microti- 
ter wells coated with BSA only and showed no significant 
adhesion (not shown). 
The  inhibition  of  transmigration  but  not  adhesion  of 
PMN by mAb C5/D5 suggested the possibility of CDllb/ 
CD18  independent,  post-adhesive  interactions  between 
epithelia  and  PMN.  If  transmigration  was  inhibited  at 
point(s) distal to initial adhesive events, one might expect 
to observe an accumulation of PMN in monolayers during 
transmigration  assays performed in the presence of mAb 
C5/D5. Indeed, a  frequent observation in our transmigra- 
tion assays was a C5/D5 dependent increase in monolayer 
associated  PMN  (Fig.  3).  While  transmigration  into  the 
opposite  chamber was inhibited  by 68  _+  11%,  there was 
nearly a  doubling of monolayer-associated PMN after in- 
Figure 3.  Effect of C5/D5 IgG 
on  PMN  migration  into  T84 
monolayers.  Basolateral  to 
apical  transmigration  assays 
were  performed  in  the  pres- 
ence  or  absence  of 25  txg/ml 
C5/D5  IgG.  In  the  graph  to 
the  right,  monolayer-associ- 
ated PMN were quantitated by 
myeloperoxidase  assay as  de- 
scribed in Materials and Meth- 
ods (four monolayers each condition). Note the number of monolayer-associated PMN is nearly doubled in the presence of C5/D5. 
However, despite an increase in monolayer-associated PMN, migration into the opposite or lower reservoir of the transwell  device was 
decreased by 68% (14.4 _+ 5.1 vs 45.2 _+ 6.8 x  10  4 migrated PMN for C5/D5 vs W6/32 CTL, respectively). To determine the position of 
PMN entrapped in the monolayer/filter after C5/D5 exposure, imaging studies were performed. The photomicrograph represents an x-z 
computer reconstructed confocal fluorescence image of a cross-section through a T84 monolayer after a PMN transmigration assay 
done in the presence of 25 p~g/ml C5/D5 IgG and stained to visualize PMN with the CDllb mAb OKM1. The epithelium, labeled Epi, 
demonstrates faintly stained basolateral membranes (solid arrow) due to the presence of C5/D5 IgG present throughout the assay (see 
Fig. 9). PMN are present within the monolayer below the apical intercellular tight junction and above the filter support. Open arrows 
designate the apical surface of the T84 monolayer. While not shown, confocal images of monolayers after transmigration in the absence 
of C5/D5 showed similar patterns of PMN migration, and background staining with normal mouse IgG instead of OKM1 revealed min- 
imal nonspecific fluorescence. Bar, 10 ~m. 
The Journal of Cell Biology,  Volume 132, 1996  442 cubation with C5/D5 IgG (Fig. 3, right). The confocal fluo- 
rescence micrograph in Fig. 3 (left) is of a T84 monolayer 
after  transmigration  in  the  presence  of  C5/D5  IgG and 
demonstrates that the quantitative increase in monolayer- 
associated PMN correlates with the accumulation of PMN 
within the epithelial monolayer. These results suggest that 
mAb C5/D5 IgG acts by inhibiting PMN movement across 
the epithelium by influencing events subsequent to initial 
CD1 lb-dependent adhesive events. 
The Antigen Defined by C51D5 Is an ~-60-kD 
Membrane Glycoprotein 
Experiments were next performed to identify the antigen 
recognized by C5/D5 IgG. Since C5/D5 IgG recognized an 
extracellular  ligand,  polarized  monolayers on permeable 
supports  were  surface  labeled  (apical  and  basolateral) 
with biotin, detergent solubilized and immunoprecipitated 
with immobilized C5/D5  IgG. The resulting immunopre- 
cipitates were then examined by SDS-PAGE followed by 
Western blots probed with peroxidase conjugated avidin. 
As shown in Fig. 4, C5/D5 IgG specifically immunoprecip- 
itates a membrane protein appearing as a broad band cen- 
tered at ~60 kD under reducing conditions  (lane 2)  and 
with a similar, perhaps slightly larger (~60--65 kD), apparent 
molecular mass under nonreducing conditions (lane 1). De- 
glycosylation experiments revealed that removal of N-linked 
sugar residues with treatment by peptide/N glycosidase F 
caused a marked reduction in the apparent molecular mass 
to N35 kD. When this deglycosylated immunoprecipitate 
was  Subsequently  subjected  to  conditions  that  remove 
O-linked sugars (O-glycanase) no further reduction in mo- 
lecular mass was apparent (lane 4). Although reduced and 
alkylated, the immunopurified protein occasionally exhib- 
ited a "laddering effect," presumably due to oligomerization 
(Fig. 4, lane 5 where a more lightly labeled band of molec- 
ular mass ~100 kD is apparent). Thus, the antigen defined by 
mAb C5/D5 is a membrane protein with an apparent mo- 
lecular mass of ~60 kD, is heavily glycosylated with N-linked 
Figure  4.  Immunoprecipita- 
tion of the antigen defined by 
C5/D5.  T84  cells,  grown  on 
5-cm  2 inserts,  were  biotiny- 
lated, solubilized  and immu- 
noprecipitated with  immobi- 
lized C5/D5 IgG as described 
in  Materials  and  Methods. 
Samples were then subjected 
to  SDS-PAGE  on  4-16% 
gradient polyacrylamide gels 
followed by Western blot, in- 
cubation  with  streptavidin- 
peroxidase and development 
by enhanced chemiluminescence. Lane 1, nonreduced C5/D5 im- 
munoprecipitate; lane 2, reduced C5/D5 immunoprecipitate; lane 
3, C5/D5 immunoprecipitate subjected  to N-linked  deglycosyla- 
tion (see Materials and Methods); lane 4, N-linked deglycosylated 
C5/D5  immunoprecipitate subsequently  subjected  to  O-linked 
deglycosylation  (see Materials and Methods);  lane 5, C5/D5 im- 
munoprecipitate, reduced and alkylated,  but showing oligomer- 
ization. 
carbohydrate and has a  core polypeptide molecular mass 
of N35 kD. 
Purification, Microsequence, and Identification of the 
C51D5 Antigen as CD47 
HT29 cells (subclone Cl 19.A) were used to bulk purify the 
antigen recognized by C5/D5.  CI 19.A cells are a well dif- 
ferentiated  human  intestinal  epithelial  cell  line  with 
growth  characteristics  more  logistically  suited  for  large- 
scale tissue culture compared to the relatively slow grow- 
ing T84 cells. The surface expression of the C5/D5 antigen, 
assessed by ELISA, on C1 19.A HT29 cells is shown in Fig. 
5 and, as with T84 cells, is shown to be responsive to IFN-',/ 
(48 h, 1,000  U/ml). An approximately twofold increase in 
surface expression of the  C5/D5  antigen was induced  by 
this cytokine and paralleled increased MHC class I expres- 
sion. Moreover, C5/D5 immunoprecipitates obtained from 
Cl 19.A HT29 cells, like those obtained from T84 cells, re- 
vealed a broad N60-kD band. While IFN-~ stimulation in- 
creased the yield of the antigen, there was no effect on the 
molecular mass of the immunoprecipitate (not shown). 
Approximately 8,500  cm  2 of IFN-~/-activated C1  19.A 
HT29 cells were used to obtain sufficient quantities of the 
C5/D5 antigen for microsequence. From 219 mg of crude 
Cl 19.A  HT29 cell lysate, ~50-75  ~g of purified protein 
was obtained, representing an overall purification of ~3,000- 
fold. Fig. 6 shows the avidin blot (A) and silver stain (B) of 
the  purified  material  eluted  from  the  CS/D5-Sepharose 
using a decreasing pH gradient. As can be seen in Fig. 6 A, 
a single biotin-labeled protein band was obtained that was 
indistinguishable  from  the  immunoprecipitate  shown  in 
Fig. 4, lane 2. Silver stain of the corresponding unconcen- 
trated fractions confirmed purification to apparent homo- 
geneity revealing a single protein band with a reduced ap- 
parent molecular mass of N60 kD (B). 
The peak protein containing fraction (Fig. 6, fraction 13) 
was concentrated,  subjected  to  SDS-PAGE  and  electro- 
1-] 
0.8- 
m 0.6-  o 
a 
O 0.4- 
0.2- 
O- 
W6/32  C5/D5 
~  (-)IFN  CTL 
(+)IFN 
Figure 5.  Expression of the  C5/D5  antigen  on  C1  19.A HT29 
cells. Surface expression  of mAb C5/D5 epitope was assayed on 
control ((-)IFN-y) and IFN-~/ stimulated  ((+) IFN-y) C1 19.A 
HT29 cells by ELISA as described in Materials  and Methods.  On 
the Y axis, surface label is represented by optical density units af- 
ter substrate addition.  Specific labeling  was determined by sub- 
tracting  the optical  density  of monolayers incubated in normal 
mouse IgG. W6/32 IgG, which strongly labels epithelial cells, was 
used as a binding control antibody at 20 I~g/ml.  Bars represent the 
mean -  SD of quadruplicates.  One of two experiments. 
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antigen  defined  by  C5/D5. 
Approximately 8,500 cm  2 of 
C1 19.A HT29 cells were ex- 
posed to IFN-~/ (1,000 U/ml, 
48 h) and subsequently  bioti- 
nylated, solubilized and passed 
through a column of immobi- 
lized C5/D5 IgG as described 
in  Materials  and  Methods. 
Bound  protein  was  eluted 
with  a pH gradient decreas- 
ing from pH 5 to pH 3 and 
fractions  of 2  ml were  col- 
lected and neutralized  as de- 
scribed  in  Materials  and 
Methods.  Both panels repre- 
sent SDS-PAGE of reduced 
and  alkylated  column  frac- 
tions (25 Ixl) on 4-16% poly- 
acrylamide  gradient  gels. 
Bound protein was observed 
to elute at pH values below 4.0. A represents a Western blot of 
the column  eluate fractions  developed  by enhanced  chemilumi- 
nescence after incubation with streptavidin-peroxidase.  B repre- 
sents the silver-stained SDS gel of the column eluate fractions. 
phoretically transferred onto a PVDF membrane followed 
by protein staining with amido black. Limited amino acid 
composition revealed ~124 pmol of protein immobilized 
on the PVDF membrane. Two different tryptic peptides 
were isolated by HPLC and sequenced yielding the follow- 
ing sequences: IEVSQLLK and STVPTDF(S)(S)A (where 
parentheses indicate residues determined with lower con- 
fidence).  Searches  for  sequence  homology  using  Gen- 
Bank/EMBL revealed a complete match for both peptides 
with a membrane protein referred to as OVTL3 (8) or in- 
tegrin-associated  protein  (IAP)  (28),  previously  deter- 
mined to be identical to CD47 (29, 34). In addition to pro- 
viding  100%  identity  with  CD47,  the  GenBank  search 
yielded  no  other  significant  sequence  homology.  Fig.  7 
shows the alignment of the two peptide sequences we ob- 
tained with that of CD47. In the lower half of Fig. 7 is a hy- 
pothetical  secondary  structural  model  first  proposed  by 
Lindberg et al. (28) with the location of the two peptide se- 
quences shown. To confirm the homology between the an- 
tigens defined by C5/D5 and CD47, an ELISA and West- 
ern blots were performed. Using microtiter wells coated 
with immunopurified C5/D5 antigen, the binding of C5/D5 
IgG  and  commercially  available  anti-CD47  antibody 
(BRIC 126)  were compared (Fig. 8 A). As can be seen in 
Fig.  8 A,  both  C5/D5  IgG and  anti-CD47  react strongly 
with  the  immunopurified  material.  Such  cross-reactivity 
was also confirmed by Western  blotting of the  commer- 
cially  available  anti-CD47  antibody  against  the  immu- 
nopurified C5/D5 antigen (not shown). 
The  identification  of the  C5/D5  antigen  as  CD47  was 
surprising given its broad tissue distribution  and the fact 
that  hybridomas  were  initially  screened  for preferential 
binding to epithelial cells over PMN. The initial screening 
assays for the C5/D5 hybridoma suggested a  low amount 
of surface labeling of T84 cells (,'-~0.10D unit above back- 
ground)  and even lower amounts on PMN.  It is possible 
that the sensitivity of the screening ELISA may have been 
limited  for  hybridoma  supernatants  with  low  antibody 
concentrations.  Given the published reports of CD47  on 
PMN (7, 28, 29, 34, 45), we tested C5/D5 for reactivity with 
human neutrophils. As shown in Fig. 8 B, flow cytometry 
of  purified,  nonpermeabilized  human  neutrophils  using 
C5/D5  IgG  revealed  substantial  surface  labeling  with 
mean channel fluorescence values of 1 and 257 for control 
versus  C5/D5-1abeled  PMN,  respectively.  Furthermore, 
immunopurification  of the  C5/D5  antigen  from  10  g  of 
PMN revealed a broadly staining protein band of ~60 kD 
that was indistinguishable from that obtained from epithe- 
lial cells (not shown). 
Localization  of C51D5 Antigen in Intestinal Epithelia 
and Mucosa 
Fig.  9  shows the  results of immunostaining  experiments, 
performed with C5/D5 IgG, on polarized T84 cells and on 
frozen sections of human colonic mucosa. As shown in A 
and C, there was minimal background staining with irrele- 
vant IgG in T84 monolayers or frozen colonic tissue sec- 
tions, respectively. In contrast, as shown in B, the en face 
Figure 7.  Alignment of pep- 
tide  sequences  of the C5/D5 
antigen  with  the  predicted 
sequence  of  CD47.  The 
amino  acid  sequences  ob- 
tained from two tryptic  pep- 
tides of protein immunopuri- 
fled  from  C5/D5  IgG  are 
shown in alignment  with the 
predicted  extracellular  im- 
munoglobulin  V-like  do- 
main  of  CD47  (IAP)  be- 
tween  residues  60  and  100. 
The  region  of  homology is 
expanded from the hypothet- 
ical  secondary  structure  as 
previously reported (28). 
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Figure 8.  The antigen  recognized  by C5/D5 IgG is CD47 and is 
expressed on neutrophils.  (A) Binding of anti-CD47  to the anti- 
gen defined by C5/D5 IgG. As described  in Fig. 6 and in Materi- 
als  and  Methods,  immobilized  C5/D5  IgG was used to immu- 
nopurify the corresponding antigen. A standard ELISA was then 
performed on microtiter wells coated with the purified  material 
that had been diluted  15-fold with PBS and allowed to bind non- 
specifically  to the  surface  (2  h,  20°C). Primary antibodies  in- 
cluded C5/D5 IgG as a positive control (1 p.g/ml) and a 1:10 dilu- 
tion of commercially available anti-human CD47  (BRIC 126). 
Optical density (OD) is shown after substrate addition to alkaline 
phosphatase-conjugated secondary antibody.  Nonspecific  back- 
ground is shown in the lane labeled CTL IgG and represents in- 
cubation with irrelevant mouse IgG. Each bar represents the av- 
erage of duplicate  determinations.  One of two experiments.  (B) 
Assessment of C5/D5 antigen on PMN by flow cytometry. PMN 
were stained  using mAb C5/D5  or no primary Ab (CTL) fol- 
lowed  by FITC-labeled goat anti-mouse antibody.  Histograms 
represent specifically stained cell numbers on the vertical axis (la- 
beled counts)  plotted against  fluorescence  on a log scale from 
20,000 cells per condition. One of two experiments. 
fluorescent staining pattern on T84 cell monolayers viewed 
in a subjunctional plane reveals a typical "chicken wire" or 
basolateral  staining  pattern.  While  the  apical  surface  of 
T84 cells showed very little staining with C5/D5 IgG, per- 
meabilization of monolayers after fixation resulted in sig- 
nificant intracellular staining (not shown). To confirm the 
relevance of the localization findings in T84 cells, similar 
studies were performed on 1 I~m frozen sections of normal 
human colon. As shown in Fig. 9 D, strong labeling of the 
basolateral  aspect  of normal  human  colonic  epithelium 
(labeled  E)  was  observed.  Also  in  agreement  with  the 
staining results on T84 monolayers, D  indicates a lack of 
staining on the apical surface of natural human colonic ep- 
ithelium.  In  addition,  panel  D  demonstrates  labeling  of 
mononuclear cells in the lamina propria. The majority of 
the lamina propria cells staining with the antibody appear 
to be leukocytes. 
Relative Contributions of Neutrophil and Epithelial C51 
D5 Antigen (CD47) to Transepithelial Migration 
Since it is clear that the antigen defined by mAb C5/D5 is 
expressed by both epithelia and PMN, experiments were 
performed to determine the relative contributions of epi- 
thelial versus PMN CD47 on transepithelial migration. To 
exclude the possibility that C5/D5 IgG influenced transmi- 
gration  by cross-linking epithelial  cells to  PMN,  experi- 
ments using Fab' fragments of C5/D5 IgG were performed 
(Fig. 10). PMN transepithelial migration in the absence of 
antibody was no different than migration in the presence 
of a control binding antibody W6/32 or the same concen- 
tration of F(ab')2 and Fab' prepared from normal mouse 
IgG (27 ___ 4.2 vs 27.3 ±  4.1, 25.2 ±  1.2, and 23.8 ±  4 x  104 
migrated PMN for no antibody vs W6/32, CTL F(ab')2 and 
Fab', respectively, NS). In contrast, transmigration in the 
presence of C5/D5 F(ab')2 and Fab' was inhibited  by 93 
and 85%, respectively (25.2  ___  1.2 vs 1.7  _-+ 0.7  x  10  4 and 
23.8 +-_ 4 vs 3.6 +__ 0.5 ×  104 migrated PMN for CTL vs C5/ 
D5 F(ab')2 and CTL vs C5/D5 Fab, respectively; P  <  0.01). 
Such results effectively rule out inhibition caused by anti- 
body mediated PMN--epithelial cross-linking or antibody 
mediated interactions with PMN Fc receptors. 
Having excluded Fc and/or cross-linking mediated inter- 
actions as possible mechanisms of the observed inhibitory 
effects of C5/D5 on PMN transepithelial migration, exper- 
iments were performed to determine the relative contribu- 
tion(s) of epithelial versus PMN CD47 to the transepithe- 
lial migration response. In such experiments, PMN or T84 
monolayers were first preincubated with control or C5/D5 
IgG and then extensively washed in HBSS to remove un- 
bound mAb. Washed, antibody pretreated cells were then 
used in standard  transmigration assays. As shown in Fig. 
11 A, preincubation of inverted T84 monolayers with C5/ 
D5 IgG resulted in 90 and 72%  inhibition of transmigra- 
tion when compared to antibody controls (20.4  ___ 1.7  vs 
2  ±  0.6 and 5.8 +-- 2.9 x  104 migrated PMN for CTL vs 50 
and 25 txg/ml C5/D5 IgG preincubation, respectively; P  < 
0.005). However, as shown in Fig. 11 B, preincubation of 
PMN with C5/D5 IgG was also highly effective in inhibit- 
ing  subsequent  transepithelial  migration  (23.8  ±  2.3  vs 
0.08  ±  2.17  x  10  4 migrated PMN for CTL vs C5/D5 IgG 
preincubation, respectively; P  <  0.001).  Such results sug- 
gest that both PMN and epithelial-associated CD47 may 
play roles in PMN transepithelial migration. The possibil- 
ity that  C5/D5  could  directly affect PMN migration was 
confirmed in assays of the effects of C5/D5 on fMLP (10 
nM  gradient)  induced  PMN  migration  across  acellular, 
collagen-coated permeable supports. As shown in Fig.  11 
C, transmigration  of PMN  across filters in the  absence 
of epithelia was also effectively inhibited by C5/D5  IgG 
(26.9  ±  0.61 vs 1.28 ±  0.1  x  104 migrated PMN for CTL vs 
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labeling  of  T84  monolayers 
and  normal  human  intestine 
with  C5/D5  IgG.  (A  and  B) 
paraformaldehyde  fixed  T84 
monolayers  were  incubated 
with C5/D5 IgG for 1 h (10 ~g/ 
ml) followed by labeling with 
FITC  conjugated  secondary 
antibody as described in Mate- 
rials  and  Methods.  Mounted, 
stained monolayers were then 
visualized by fluorescence con- 
focal  microscopy.  A  repre- 
sents the control, stained with 
normal  mouse  IgG.  B  repre- 
sents an X-Y fluorescence im- 
age in  the mid-zone (subjunc- 
tional)  of  a  T84  monolayer 
stained with C5/D5 that shows a 
chicken  wire  or  basolateral 
membrane  staining  pattern. 
(C and D) Paraformaldehyde- 
fixed 3  ~m frozen sections of 
human colon labeled with C5/ 
D5 IgG followed by FITC-con- 
jugated secondary as described 
above  and  in  Materials  and 
Methods.  Panel  C  represents 
the nonspecific staining control using normal mouse IgG. D represents C5/D5 staining of colonic crypts and lamina propria leukocytes. 
L designates the colonic lumen that is closest to the apical aspect of the intestinal epithelium designated E. Note the strong labeling of 
the basal and lateral aspects of the epithelium and absence of labeling of the apical surface. Beneath the epithelium is the interstitium (/) 
or lamina propria that shows abundant inflammatory cells staining positively  with C5/D5 IgG. Bar, 10 ~m. 
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Figure 10.  C5/D5  Fab'/F(ab')2 fragments inhibit PMN transepi- 
thelial migration. Fab'(25  ~g/ml) and F(ab')2 (20  ~g/ml) frag- 
ments of C5/D5 IgG were prepared by pepsin digestion and as- 
sayed for  effects on  apical-to-basolateral transmigration  using 
EDTA pretreated T84 monolayers as described in Fig. 1 and in 
Materials and  Methods.  As controls, normal  mouse  IgG1  was 
pepsin digested in parallel with C5/D5  to make F(ab')2/Fab. In 
addition, intact C5/D5 (C5/D5 tgG) and W6/32 were used (25 p~g/ 
ml). Bars represent the mean of 4 _+ SD monolayers for each con- 
dition (28 monolayers total). One of two experiments. 
migration in the presence of C5/D5 IgG, respectively; P  < 
0.001). 
Experiments were also performed both to examine the 
selectivity of C5/D5-mediated inhibition of neutrophil func- 
tion and to exclude the possibility that C5/D5-mediated in- 
hibition of PMN migration was a  consequence of C5/D5- 
mediated activation (i.e., due to desensitization). As shown 
in Table I, treatment  of PMN  with saturating concentra- 
tions  of  C5/D5  IgG  did  not  influence  PMN  superoxide 
production or degranulation. In the presence of antibody, 
addition of saturating concentrations of fMLP resulted in su- 
peroxide production that was indistinguishable from that 
in the absence of antibody. Furthermore, addition of C5/ 
D5 IgG failed to induce the release of primary or second- 
ary granules, nor did it augment  or inhibit degranulation 
after stimulation with fMLP. 
Effects of C5/D5 IgG on Transendothelial Migration 
Since it was recently reported that integrin associated pro- 
tein (CD47) plays a role in transendothelial migration (13) 
we  tested  C5/D5  for  effects  on  PMN  migration  across 
monolayers of HUVECS.  As shown in Fig. 12, migration 
of PMN across monolayers of HUVECS was markedly in- 
hibited (91%) by C5/D5 IgG (3.8 +- 2.7 vs 45.8 _+ 4.4 ×  104 
migrated PMN for C5/D5  vs W6/32 ctl, respectively; P  < 
0.001). 
Discussion 
Since little is known about the molecular interactions be- 
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Figure 11.  Relative contribu- 
tions of neutrophil versus ep- 
ithelial  CD47 to PMN trans- 
epithelial migration. (A) C5/ 
D5 IgG at the concentrations 
in  parentheses  (~g/ml)  was 
preincubated  with  inverted 
T84 monolayers (20°C,  1 h) 
before extensive washing fol- 
lowed  by  immediate  use  in 
basolateral-to-apical  trans- 
migration assays as described 
in  Materials  and  Methods. 
As  a  control,  monolayers 
were  preincubated  with  50 
~g/ml W6/32  IgG. (B) PMN 
were  preincubated  with 
equivalent  doses  of  C5/D5 
IgG or the binding, noninhib- 
itory control antibody W6/32 (25 ~g/ml) before extensive washing followed by immediate use in basolateral-to-apical transmigration as- 
says as described in Materials and Methods. (C) Collagen-coated permeable supports preincubated in media overnight were used in 
transmigration assays as above except that antibody (10 ixg/ml) was present in both the upper and lower chambers. Migration is shown 
in the absence ((-)fMLP) or presence ((+)fMLP) of a 10-nM fMLP transwell gradient. In the presence of an fMLP gradient, transmi- 
gration in the presence of a control binding antibody W6/32 is compared to that in the presence of C5/D5 IgG. Bars represent the mean 
--+ SD of four monolayers for each condition (36 monolayers total). One of two experiments. 
tween PMN and columnar epithelia during transepithelial 
migration,  experiments  were performed to obtain probes 
useful in further characterizing this important process.  In 
this study we have raised and characterized a monoclonal 
antibody,  C5/D5,  which  largely  abolishes  the  ability  of 
PMN to cross monolayers of the polarized  crypt-like hu- 
man intestinal  epithelial  cell line, T84.  Although CDllb/ 
CD18-mediated  PMN  adhesion  to  the  epithelial  surface 
appears to mediate initial contacts between PMN and co- 
lumnar epithelial cells (41) and is required for consumma- 
tion of the transmigration  response  (43),  the C5/D5  anti- 
gen  does  not  appear  to  represent  a  ligand  for  CDllb/ 
CD18. The C5/D5 antigen is shown to represent CD47, an 
Table L Effect of C5/D5 lgG on Neutrophil 02- Production and 
Degranulation 
Oxidase activity  *  2  ° Granules;  I ° Granules; 
Condition*  (nmol O2-/10  6 PMN)  lactoferrin  ~  myeloperoxidase  ~ 
C5/D5 IgG  0  0,12  0.02 
C5/D5  +  fMLP  8.8  0.96  0.03 
fMLP  9.3  0.97  0.03 
PMA  15.8  1.49  0.03 
W6/32  0  0.13  0,03 
W6/32 +  fMLP  9.0  0.73  0.03 
PMN only  0  0.12  0.03 
dHCB +  fMLP  0.74 
Solubilized PMN  1.49 
*Suspensions of 106/ml PMN were preincubated for 10 min with 10 i~g/ml C5/D5 
IgG or control W6/32 IgG before stimulation for 5 min with fMLP (100 nM). Con- 
trois included stimulation with fMLP alone (5 min), PMA alone (5 min; 100 uglml) or 
preincubation with dihydrocytochalasin B  (dHCB) (4 rain at 5  I~g/ml) followed by 
fMLP (5 min). 
*For O~- assays, P/vlN were suspended in cytocrome C buffer in presence or absence 
of superoxide dismutase and catalase, and stimulated for 5 min. The superoxide dis- 
mutase inhibitable reduction of cytochrome C  was then determined on the cell-free 
supernatants as described in Materials and Methods. 
~Lactoferrin  was determined by ELISA, and myeloperoxidase by enzymatic activity 
as described in Materials and Methods. Values represent optical density after sub- 
strate addition. 
Each value was determined from 1 ml of cells (106 PMN). One of two experiments. 
unusual  member  of the  immunoglobulin  superfamily.  In 
keeping with the broad tissue distribution of CD47, previ- 
ously reported  to  be  expressed  on  leukocytes,  platelets, 
endothelial  cells, placenta,  ovarian cancer cells,  and vari- 
ably on epithelia  (7,  8, 20, 34), we now report  CD47 ex- 
pression on the basolateral  surface of human colonic epi- 
thelial  cells (cultured lines and natural  tissue).  Lastly, we 
provide  evidence  that  implicates  contributions  of  both 
PMN and epithelial-derived  CD47 in the process of trans- 
epithelial migration. 
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Figure 12.  C5/D5 IgG inhibits  PMN transendothelial migration. 
Dose responses of C5/D5  IgG on PMN  across monolayers of 
HUVECs were performed exactly as described in Fig.  1 and in 
Materials and Methods. The concentration of antibody in ~g/ml 
is shown in parentheses.  As controls, transmigration in the ab- 
sence of antibody (NoAb) and W6/32 (20 Ixg/ml) are shown. Each 
bar represents the mean ___ SD of triplicate determinations. One 
of two experiments. 
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ovarian tumor marker (8) using the monoclonal antibody 
OVLT3 as a  tool. The OVLT3 antibody was  of interest 
since it recognized an epitope on ovarian carcinoma that 
was initially thou.ght to be rarely found on normal human 
tissues  (8). The identical sequence was subsequently ob- 
tained in studies aimed at identifying an IAP; so named 
since it appeared to associate with integrins from the 133 
family (7, 28). Studies initially defining IAP were as ele- 
gant as they were complex. Human PMN were observed to 
express a  ligand binding specificity for Arg-Gly-Asp se- 
quences that were blocked by monoclonal antibody B6H12. 
B6H12 immunoprecipitated an integrin-like heterodimer 
from surface-labeled PMN  and  platelets  (22).  The  inte- 
grin-like protein appearing in B6H12 immunoprecipitates 
was termed the leukocyte response integrin which, while 
potentially displaying unusual  and  interesting functional 
characteristics, remains structurally uncharacterized (9, 23, 
47, 54). However, B6H12 immunoprecipitates derived from 
placenta contain the ~xv[33  integrin and those from platelets 
contain a protein that appears to be 133 (7), raising the pos- 
sibility that the integrin-like molecule in the PMN-derived 
immunoprecipitates  is  related  to  the  133  integrin  family. 
Consistent  with  the  proposed  connection between  IAP 
and the 133 family were a series of observations that indi- 
cate that B6H12 is able to inhibit av133-mediated binding of 
erythroleukemia  cells  to  vitronectin-coated  beads  (28). 
However, subsequent to the original immunoprecipitation 
studies  (22),  it  became  clear  that  the  integrin-like  het- 
erodimer present  in  immunoprecipitates  obtained  using 
B6H12 represented coprecipitating proteins that  did not 
directly possess the epitope recognized by B6H12. Rather 
B6H12 recognized a  smaller protein for which the  term 
IAP was subsequently applied (7). The antigen recognized 
by B6H12 (IAP) was subsequently cloned and recognized 
to represent CD47 (28, 29). 
A  structural  model  of  CD47  has  been  presented  by 
Brown and colleagues (28) and consists of: a single amino 
terminus, an IgV-like extracellular domain harboring sev- 
eral  potential  N-glycosylation sites,  five  putative  mem- 
brane spanning domains, and a cytoplasmic carboxy termi- 
nus.  As  shown  in  Fig.  7,  the  sequences  obtained  in  the 
current study are expressed in the IgV-like domain. Given 
the multiple membrane spanning domains, and the ability 
of the B6H12 antibody to interfere with vitronectin bind- 
ing  (an  event that  involves Ca  2÷  signaling),  it  has  been 
speculated that B6H12 might be involved in signal trans- 
duction,  perhaps  even  as  a  calcium  channel  (46).  Cur- 
rently, there is little direct evidence to support this inter- 
esting proposal. However, monoclonal antibodies to CD47 
are  able  to  inhibit  fibronectin-stimulated  signaling  re- 
sponses in human umbilical vein endothelial cells without 
interfering with endothelial adhesion to fibronectin-coated 
plastic (46). Thus, it appears that CD47 antibodies might, 
under specific circumstances, be  able  to uncouple adhe- 
sion from downstream signaling responses. 
Although  the precise role(s) that  CD47  might play in 
cell  regulation/signaling/etc,  remain  to  be  defined,  this 
study and  a  recent report investigating neutrophil-endo- 
thelial interactions suggest that this protein may also influ- 
ence such cell-cell interactions. Cooper et al. (13) have re- 
cently reported  that  the  B6H12  antibody inhibits  PMN 
movement across endothelial monolayers in response to 
gradients of fMLP and IL-8 or in response to endothelial 
TNFa  exposure.  Interestingly,  while  exposure  of either 
PMN or endothelial cells to B6H12 inhibited PMN migra- 
tion across TNFa stimulated HUVECS, endothelial expo- 
sure to this antibody only partially inhibited IL-8-induced 
transmigration. Since PMN exposure to the antibody fully 
inhibited transmigration in response to IL-8, these investi- 
gators concluded that both PMN- and endothelial-associ- 
ated CD47 may play a role in transendothelial migration 
of PMN.  In  this  report,  we  confirm  the  importance  of 
CD47  in  transendothelial migration  as  demonstrated  by 
the marked inhibitory effect of C5/D5 IgG on PMN migra- 
tion across monolayers of HUVECS in response to fMLP. 
In addition, we demonstrate that the inhibitory effects ob- 
served with C5/D5 are not mediated by Fc interactions or 
cell--cell cross-linking due to shared epitopes. 
Given the columnar height of intestinal epithelial cells, 
migration of PMN  across the paracellular space may be 
complex, and it is unclear at what "step" the C5/D5 medi- 
ated inhibition occurs. Since C5/D5  IgG failed to inhibit 
PMN-epithelial adhesion or T84 cell adhesion to CDllb/ 
CD18, it appears that the CD47-mediated event(s) occur 
distal to at least one CDllb/CD18-dependent adhesive in- 
Figure 13.  Multistep model of neutrophil  transepithelial  migra- 
tion. Neutrophil  migration across intestinal epithelium naturally 
occurs in the basolateral-to-apical  direction and leads to revers- 
ible disruption  of tight junctions  (denoted by the heavy bar be- 
tween center and left cell) and ultimately results in collection of 
PMN  on the lumenal  surface  (termed crypt abscess by histo- 
pathologists). An initial adhesive event involves PMN adhesion 
to the  epithelial  cell basolateral  domain  and  is dependent on 
CDllb/CD18 (41, 43) whereas a subsequent event occurring dur- 
ing migration of PMN between epithelial ceils is dependent on 
CD47 (current study). 
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In this multistep model of transepithelial migration, PMN, 
after extravasation, initially adhere to the basolateral as- 
pect of intestinal epithelial cells in a CDllb/CD18-medi- 
ated fashion. Such events are readily captured in modified 
epithelial-PMN  adhesion assays  (41) or in assays of epi- 
thelial  adhesion to purified  CDllb/CD18.  Subsequently, 
PMN migrate over the extended lateral surface of intesti- 
nal epithelial ceils in a manner that is dependent, at least 
in part, on CD47.  Transmigrating PMN then disrupt the 
tight junction (37, 38)  and enter the lumen of the crypt, 
forming a crypt abscess.  Such a model would predict that 
inhibition of CD47-mediated  transmigration might cause 
an accumulation of PMN within the epithelium. Indeed, as 
shown in Fig.  3, we have observed increased monolayer- 
associated PMN in our transwell assays using C5/D5 IgG. 
Such findings, however, have always been accompanied by 
dramatic inhibition of the flux of PMN into the lower res- 
ervoir of the transwell device. 
The  precise  role  of  epithelial-derived  CD47  in  PMN 
transepithelial migration is not clear. These results might 
be  explained if CD47 was  involved in homeotypic adhe- 
sive  interactions  between  PMN  and epithelia.  However, 
we  have  failed  to  demonstrate  adhesion  of T84  cells  to 
CD47  purified  by  different  immunoaffinity  techniques. 
The  current  observations  suggest  that  epithelial  CD47 
may  indeed  contribute  to  the  efficiency  of PMN  move- 
ment across epithelia. It is quite clear that events mediated 
by PMN-associated CD47 are required for successful com- 
pletion  of transepithelial  migration.  Understanding  how 
CD47 mediates this process will require a more fundamen- 
tal knowledge  of the functional role this membrane  pro- 
tein serves in eukaryotic cells. 
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